Catalogers explore a new frontier: establishing a NEASC evidence center

This article describes how cataloging staff at the Roger Williams University Library established, managed, and planned to preserve an online NEASC Evidence Center for the University’s reaccreditation process. It highlights use of MARC and AACR2rev for effective organization of the Center’s records and the continuing importance of professional cataloging skills

The Future of Institutional Repositories at Small Academic Institutions: Analysis and Insights

Institutional repositories (IRs) established at universities and academic libraries over a decade ago, large and small, have encountered challenges along the way in keeping faith with their original objective: to collect, preserve, and disseminate the intellectual output of an institution in digital form. While all institutional repositories have experienced the same obstacles relating to a lack of faculty participation, those at small universities face unique challenges. This article examines causes of low faculty contribution to IR content growth, particularly at small academic institutions. It also offers a first-hand account of building and developing an institutional repository at a small university. The article concludes by suggesting how institutional repositories at small academic institutions can thrive by focusing on classroom teaching and student experiential learning, strategic priorities of their parent institutions

International Conference on Dublin Core and Metadata Application 2004

The International Conference on Dublin Core and Metadata Applications took place on October 11-14, 2004 in Shanghai, China. It was the fourth in a series of expanded Dublin Core conferences that included a conference, tutorials and workshops. Prior to the first in this series of conferences held in Tokyo in 2001, eight Dublin Core workshop series had been held in various North American and European countries starting in 1995. These workshops and conferences have provided a forum where researchers and practitioners can exchange new ideas and demonstrate the development of metadata standards and applications from practical aspects

The happiness - suicide paradox

Suicide is an important scientific phenomenon. Yet its causes remain poorly understood. This study documents a paradox: the happiest places have the highest suicide rates. The study combines findings from two large and rich individual-level data sets—one on life satisfaction and another on suicide deaths—to establish the paradox in a consistent way across U.S. states. It replicates the finding in data on Western industrialized nations and checks that the paradox is not an artifact of population composition or confounding factors. The study concludes with the conjecture that people may find it particularly painful to be unhappy in a happy place, so that the decision to commit suicide is influenced by relative comparisons.Happiness ; Suicide

Increasing Colorectal Cancer Screening Awareness: An Innovative Participatory Intervention

Among American men and women, colorectal cancer (CRC) is the third most commonly diagnosed cancer as well as the third leading cause of cancer death. The importance of CRC screening is supported by improved survival rates associated with early diagnosis. Despite these well known facts, half of eligible adults in the United States have not been tested. This paper reports on a novel intervention utilizing a uniquely designed community-based CRC education program to promote CRC awareness and increase participant’s intention to participate in CRC screening. Trained teams of oncology nurses worked with senior level nursing students who provided a two-tier intervention that engaged both children and adults. Surprisingly, a survey of participants indicated that within this sample, screen rates were 84.1%. This is higher than the Healthy People 2020 screening target of 70.5%. Participants in the educational intervention program still reported the program increased their awareness of CRC and the need for screening. Results also show that a doctor’s recommendation influences a person’s decision to participation in CRC screening

The Parton Structure of the Nucleon and Precision Determination of the Weinberg Angle in Neutrino Scattering

A recently completed next-to-leading-order program to calculate neutrino cross sections, including power-suppressed mass correction terms, has been applied to evaluate the Paschos-Wolfenstein relation, in order to quantitatively assess the validity and significance of the NuTeV anomaly. In particular, we study the shift of $\sin^2 \theta_{\mathrm{W}}$ obtained in calculations with a new generation of PDF sets that allow $s(x)\neq \bar{s}(x)$, enabled by recent neutrino dimuon data from CCFR and NuTeV, as compared to the previous $s = \bar{s}$ parton distribution functions like CTEQ6M. The extracted value of $\sin^2 \theta_{\mathrm{W}}$ is closely correlated with the strangeness asymmetry momentum integral $\int_{0}^{1}x[s(x)-\bar{s}(x)] dx$. We also consider isospin violating effects that have recently been explored by the MRST group. The results of our study suggest that the new dimuon data, the Weinberg angle measurement, and other data sets used in global QCD parton structure analysis can all be consistent within the Standard Model.Comment: 4 page

Emerging Methods to Objectively Assess Pruritus in Atopic Dermatitis.

INTRODUCTION:Atopic dermatitis (AD) is an inflammatory skin disease with a chronic, relapsing course. Clinical features of AD vary by age, duration, and severity but can include papules, vesicles, erythema, exudate, xerosis, scaling, and lichenification. However, the most defining and universal symptom of AD is pruritus. Pruritus or itch, defined as an unpleasant urge to scratch, is problematic for many reasons, particularly its negative impact on quality of life. Despite the profoundly negative impact of pruritus on patients with AD, clinicians and researchers lack standardized and validated methods to objectively measure pruritus. The purpose of this review is to discuss emerging methods to assess pruritus in AD by describing objective patient-centered tools developed or enhanced over the last decade that can be utilized by clinicians and researchers alike. METHODS:This review is based on a literature search in Medline, Embase, and Web of Science databases. The search was performed in February 2019. The keywords were used "pruritus," "itch," "atopic dermatitis," "eczema," "measurements," "tools," "instruments," "accelerometer," "wrist actigraphy," "smartwatch," "transducer," "vibration," "brain mapping," "magnetic resonance imaging," and "positron emission tomography." Only articles written in English were included, and no restrictions were set on study type. To focus on emerging methods, prioritization was given to results from the last decade (2009-2019). RESULTS:The search yielded 49 results in PubMed, 134 results in Embase, and 85 results in Web of Science. Each result was independently reviewed in a standardized manner by two of the authors (M.S., K.L.), and disagreements between reviewers were resolved by consensus. Relevant findings were categorized into the following sections: video surveillance, acoustic surveillance, wrist actigraphy, smart devices, vibration transducers, and neurological imaging. Examples are provided along with descriptions of how each technology works, instances of use in research or clinical practice, and as applicable, reports of validation studies and correlation with other methods. CONCLUSION:The variety of new and improved methods to evaluate pruritus in AD is welcomed by clinicians, researchers, and patients alike. Future directions include next-generation smart devices as well as exploring new territories, such as identifying biomarkers that correlate to itch and machine-learning programs to identify itch processing in the brain. As these efforts continue, it will be essential to remain patient-centered by developing techniques that minimize discomfort, respect privacy, and provide accurate data that can be used to better manage itch in AD

Opioid Use as a Predictor of Health Care Use and Pain Outcomes: Analysis of Clinical Trial Data

Objective . To examine effects of pre-enrollment opioid use on outcomes of a 12-month collaborative pain care management trial. We hypothesized that participants with opioid use would have worse pain at baseline; use more health care services and analgesics; and have worse pain outcomes during the trial. Design . Secondary analysis of randomized controlled trial data. Setting . Veterans Affairs (VA) primary care. Subjects . Patients age 18-65 years with chronic pain of at least moderate severity who were enrolled in a 12-month pragmatic trial of a telephone-based collaborative care intervention for chronic musculoskeletal pain. Methods . Participants were categorized as opioid users (n = 84) or non-users (n = 166) at baseline and trial randomization was stratified by opioid use. We used logistic regression to examine cross-sectional associations with baseline opioid use and mixed-effect models for repeated measures to examine baseline opioid use as a predictor of Brief Pain Inventory (BPI) scores over 12 months. Results . At baseline, 33.6% reported use of prescribed opioids. Baseline opioid users had higher baseline BPI scores and higher health-related disability than non-users. Baseline opioid users also had more outpatient visits (15.0 vs. 10.1; p = 0.001) and received more analgesics (p < 0.001) during the trial. In the final multivariable model examining effects of baseline opioid use on BPI over 12 months, opioid users and nonusers had a non-significant difference of 0.25 points (p = 0.098). In conclusion, although baseline opioid users had worse pain at baseline and used more health care during the study, response to the intervention was not significantly modified by pre-existing opioid therapy

Factors Influencing Sleep Difficulty and Sleep Quantity in the Citizen Pscientist Psoriatic Cohort.

IntroductionSleep is essential for overall health and well-being, yet more than one-third of adults report inadequate sleep. The prevalence is higher among people with psoriasis, with up to 85.4% of the psoriatic population reporting sleep disruption. Poor sleep among psoriasis patients is particularly concerning because psoriasis is independently associated with many of the same comorbidities as sleep dysfunction, including cardiovascular disease, obesity, and depression. Given the high prevalence and serious consequences of disordered sleep in psoriasis, it is vital to understand the nature of sleep disturbance in this population. This study was designed to help meet this need by using survey data from Citizen Pscientist, an online patient portal developed by the National Psoriasis Foundation.MethodsOur analysis included 3118 participants who identified as having a diagnosis by a physician of psoriasis alone or psoriasis with psoriatic arthritis. Demographic information, psoriasis severity and duration, sleep apnea status, smoking and alcohol consumption, itch timing, and sleep characteristics were included. Two separate multivariate logistic regression models in STATA were used to determine whether the presence of psoriatic arthritis, age, gender, body mass index, comorbid sleep apnea, psoriasis severity, timing of worst itch, smoking status, or high-risk alcohol consumption were associated with sleep difficulty or low sleep quantity, defined by the American Academy of Sleep Medicine as less than 7 h of sleep per night on average.ResultsResults from the multivariate logistic regressions found that sleep difficulty was associated with psoriatic arthritis (OR 2.15, 95% CI [1.79-2.58]), female gender (2.03 [1.67-2.46]), obese body mass index (BMI ≥ 30) (1.25 [1.00-1.56]), sleep apnea (1.41 [1.07-1.86]), psoriasis severity of moderate (1.59 [1.30-1.94]) or severe (2.40 [1.87-3.08]), and smoking (1.60 [1.26-2.02]). Low sleep quantity was associated with obese BMI (1.62 [1.29-2.03]), sleep apnea (1.30 [1.01-1.68]), psoriasis severity of moderate (1.41 [1.16-1.72]) or severe (1.40 [1.11-1.76]), and smoking (1.62 [1.31-2.00]). Sleep difficulty and low sleep quantity were not associated with age, alcohol consumption, or timing of worst itch.ConclusionThese results are potentially meaningful in several aspects. We identify an important distinction between sleep difficulty and sleep quantity in psoriatic disease, whereby having psoriatic arthritis and being female are each associated with sleep difficulty despite no association with low sleep quantity. Furthermore, there is conflicting evidence from prior studies as to whether psoriasis severity is associated with sleep difficulty, but this well-powered, large study revealed a strong, graded relationship between psoriasis severity and both sleep difficulty and low sleep quantity. Overall, our results show that both sleep difficulty and low sleep quantity were associated with multiple factors in this analysis of a large psoriatic cohort. These findings suggest that dermatologists may gather clinically useful information by screening psoriatic patients for trouble sleeping and low sleep quantity to identify potential comorbidities and to more effectively guide disease management